Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

762 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of rifampicin administration on CYP induction in a dermatomyositis patient with vasospastic angina attributable to nilmatrelvir/ritonavir-induced blood tacrolimus elevation: A case report.
Akamatsu H, Kohno Y, Hashizume J, Nakagawa H, Kodama Y, Kawano H, Maemura K, Ohyama K. Akamatsu H, et al. Among authors: ohyama k. J Infect Chemother. 2024 Feb 13:S1341-321X(24)00035-7. doi: 10.1016/j.jiac.2024.02.006. Online ahead of print. J Infect Chemother. 2024. PMID: 38360184
Immune complexome analysis of a rich variety of serum immune complexes identifies disease-characteristic immune complex antigens in systemic sclerosis.
Kutsuna YJ, Iwamoto N, Ichinose K, Aibara N, Nakashima K, Nakamura H, Koike Y, Murota H, Ueki Y, Miyamoto H, Hashizume J, Kodama Y, Nakashima M, Kawakami A, Ohyama K. Kutsuna YJ, et al. Among authors: ohyama k. J Autoimmun. 2023 Jan;134:102954. doi: 10.1016/j.jaut.2022.102954. Epub 2022 Nov 24. J Autoimmun. 2023. PMID: 36436353
Letrozole ameliorates liver fibrosis through the inhibition of the CTGF pathway and 17β-hydroxysteroid dehydrogenase 13 expression.
Sakai N, Kamimura K, Miyamoto H, Ko M, Nagoya T, Setsu T, Sakamaki A, Yokoo T, Kamimura H, Soki H, Tokunaga A, Inamine T, Nakashima M, Enomoto H, Kousaka K, Tachiki H, Ohyama K, Terai S. Sakai N, et al. Among authors: ohyama k. J Gastroenterol. 2023 Jan;58(1):53-68. doi: 10.1007/s00535-022-01929-w. Epub 2022 Oct 27. J Gastroenterol. 2023. PMID: 36301364
Modeled Hepatic/Plasma Exposures of Fluvastatin Prescribed Alone in Subjects with Impaired Cytochrome P450 2C9*3 as One of Possible Determinant Factors Likely Associated with Hepatic Toxicity Reported in a Japanese Adverse Event Database.
Adachi K, Ohyama K, Tanaka Y, Saito Y, Shimizu M, Yamazaki H. Adachi K, et al. Among authors: ohyama k. Biol Pharm Bull. 2024;47(3):635-640. doi: 10.1248/bpb.b24-00012. Biol Pharm Bull. 2024. PMID: 38494736 Free article.
762 results